〔Abstract〕 Objective To explore the research trajectory and development trends in Traditional Chinese Medicine (TCM) studies on triple-negative breast cancer (TNBC) from the recent literature over the past decade. Methods Searching-work was conducted in the China National Knowledge Infrastructure (CNKI) database for literature on the treatment of TNBC with TCM from January 1, 2013, to December 1, 2023. CiteSpace 6.2 software was utilized for visual analysis of the literature's keywords, authors, and institutions. Results The publication volume of TCM literature on TNBC treatment has shown an increasing trend over the past ten years. Co-word and cluster analysis of the collaboration network revealed that TCM research on TNBC mainly focuses on apoptosis, chemotherapy, proliferation, metastasis, immunity, and quality of life, with molecular docking emerging as a new research hotspot. Burst analysis indicated that autophagy has become a hotspot in the past five years. The author with the highest publication volume is Liu Sheng, and the institution with the most publications is Beijing University of Chinese Medicine. Conclusion TCM research on TNBC is in a rising phase. Current hotspots mainly concentrate on the application of TCM to enhance immune function in TNBC patients, improve quality of life, aid chemotherapy, and elucidate mechanisms of cell proliferation and apoptosis. Molecular docking and autophagy represent new frontiers in research that warrant further exploration and investigation.